Our Impact

Transforming research and redefining what’s possible. Our efforts to change the trajectory of ALS research are unlocking critical insights and accelerating the path to effective treatments.

A radical vision for major impact

At Target ALS, we didn’t just join the fight—we changed the rules.

Years of slow progress and the unrelenting speed of ALS inspired us to develop a revolutionary new model for research, the Innovation Ecosystem. Our approach is rapidly advancing the pace of science, breaking down barriers to progress, and fostering collaboration to enable discovery.

Through the research we fund, enable, and conduct, we are fast-tracking breakthroughs and uniting academia, pharma and biotech, venture capital, government, other ALS nonprofits, and the ALS community. Together, we are making research the highest form of care, and it’s showing.

Powering progress

Our game-changing model transforms how ALS research happens—and the impact is clear.

Icon

750+ research grants funded

Backing the most impactful science—free from bias or boundaries—to accelerate progress in ALS research.

Icon

$80M+ invested in ALS research

Funding research at every level to accelerate the path to breakthroughs.

Icon

58% of funded projects have led to drug discovery programs

Driving progress with a collaborative approach.

Icon

12 clinical trials developed from funded projects

Contributing directly to the launch of clinical trials that aim to bring new treatments to those living with ALS.

Icon

1800+ partners using our resources

Accelerating progress by offering no-strings-attached resources with our Research Cores to scientists around the world.

Icon

14 active global research sites

Conducting research through the largest and most inclusive global ALS study ever.

Real-world impact

Unlocking discovery 

The next big ALS breakthrough could come from anywhere. That’s why access must drive innovation. We offer the global research community unrestricted, no-strings-attached access to some of the most comprehensive ALS biosample and tool collections available—resources that would otherwise be out of reach for many labs.

No other nonprofit in ALS does this.

Our Research Cores are helping scientists push the boundaries of what’s possible.

See our Research Cores

“Without Target ALS’s access to these stem cell lines, the process of creating such models would be significantly more costly and time-consuming… these stem cell banks are sometimes not publicly available, so it’s been instrumental in advancing our research.”

Author

Dr. Kathryn H. Morelli, Ph.D.

Assistant Professor at the University of Vermont Dept. of Neurological Sciences

Sharing data without barriers

We’re speeding up the path to discoveries by breaking down barriers like paywalls, red tape, and intellectual property restrictions. Our Data Engine is a first-of-its-kind platform giving researchers around the world free access to powerful ALS data—all in one place. 

Built in partnership with DNAstack and Verily, this Research Core includes easy-to-use tools to search, explore, and analyze multi-omic data linked to real biosamples.

The next big ALS breakthrough could come from anywhere. That’s why access must drive innovation. We offer the global research community unrestricted, no-strings-attached access to some of the most comprehensive ALS biosample and tool collections available—resources that would otherwise be out of reach for many labs.

We’re speeding up the path to discoveries by breaking down barriers like paywalls, red tape, and intellectual property restrictions. Our Data Engine is a first-of-its-kind platform giving researchers around the world free access to powerful ALS data—all in one place. 

Built in partnership with DNAstack and Verily, this Research Core includes easy-to-use tools to search, explore, and analyze multi-omic data linked to real biosamples.

“The way I’ve used the resource thus far has really helped me with hypothesis generation… It’s a really big deal, because that stuff just takes so much time. Target ALS runs a very tight ship, so I have trusted this resource implicitly.”

Author

Cooper Penner

MD-PhD Candidate, University of Pennsylvania Department of Neuroscience

Empowering global research 

The research we conduct is unlocking insights by expanding the diversity and global reach of ALS studies. Our ALS Global Research Initiative (AGRI), with its Global Natural History Study and Community-Based Pop-Up Clinics, is the largest and most inclusive ALS research study ever.

While other studies collect samples and data, the critical information participants provide isn’t made available immediately, like in our studies. In some cases, samples can sit on shelves for years—further delaying urgently needed discoveries. 

We invite communities into our studies and immediately deliver samples to accelerate progress.